Current partner codePEPTIDESDE

Recruitment-status index

ActivePeptide Trials.

Explore every peptide study grouped under active in the local registry snapshot. Check the source record before relying on recruitment status, because registry entries can change.

Studies
410
Recruiting
0
Completed
0
Results posted
22
Countries
73
Avg enrollment
336

Velocity

Active trials by start year

Study start year · indexed snapshot

1371036934019971997: 1 trials1998: 0 trials1999: 0 trials2000: 0 trials2001: 0 trials2002: 0 trials20032003: 1 trials2004: 1 trials2005: 0 trials2006: 2 trials2007: 2 trials2008: 1 trials20092009: 0 trials2010: 0 trials2011: 0 trials2012: 3 trials2013: 3 trials2014: 7 trials20152015: 2 trials2016: 7 trials2017: 7 trials2018: 7 trials2019: 13 trials2020: 15 trials20212021: 24 trials2022: 19 trials2023: 33 trials2024: 50 trials2025: 67 trials2026: 137 trials20272027: 7 trials20282028: 1 trials

Development

Trials by phase

Early Phase 110
Phase 136
Phase 2112
Phase 394
Phase 454

Industry

Leading sponsors

Novo Nordisk22
Eli Lilly15
Amgen9
BioMarin6
Zealand Pharma5
Adenocyte, LLC4
Hoffmann-La Roche4
Novartis4

Therapeutic areas

Condition groups

Weight loss84
Type 2 diabetes32
Pain14
Brain health13
Inflammation7
Longevity6
Hair loss1

Study explorer

Search this collection.

410 matching studies